Category Archives: News and Events

BriaCell Anti-Cancer Technology Published in Leading Cancer Drug Discovery Journal
June 24, 2022

Anti-Cancer activity of BriaCell’s lead candidate, Bria-IMT™, in advanced breast cancer patients was published in ...

BriaCell Adds Additional Clinical Sites to Broaden Patient Access and Further Boost Enrollment
May 18, 2022

PHILADELPHIA and VANCOUVER, British Columbia, May 18, 2022 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: ...

BriaCell Receives FDA Fast Track Approval for Targeted Breast Cancer Immunotherapy
April 13, 2022

U.S. Food and Drug Administration (FDA) has granted Fast Track status to BriaCell’s lead candidate, ...

BriaCell Presents Development Details of Bria-OTS(TM) Platform Technology at the American Association for Cancer Research (AACR) Annual Meeting 2022
April 12, 2022

Based on clinical data with Bria-IMT™, BriaCell has developed Bria-OTS™, an off-the-shelf (i.e. pre-manufactured) personalized ...

BriaCell advances preparatory work for new Bria-OTS(TM) breast cancer clinical trial
April 7, 2022

Bria-OTS™ would build on BriaCell’s existing clinical trial data with Bria-IMT™, treating each patient with ...

BriaCell Adds Two Clinical Trial Sites to Accelerate Patient Enrollment
February 28, 2022

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 28, 2022 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: ...

BriaCell Appoints Leading Immunologist Dr. Alexander Kharazi to its Scientific Advisory Board
February 23, 2022

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: ...

BriaCell Appoints Renowned Oncologist, Giuseppe Del Priore, MD, MPH, as Chief Medical Officer
February 16, 2022

PHILADELPHIA and VANCOUVER, British Columbia, Feb. 16, 2022 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: ...

BriaCell to Present at the AACR 2022; Provides Corporate Buyback and Insider Buying Update
February 10, 2022

BriaCell selected to present at the American Association for Cancer Research (AACR) Annual Meeting 2022 ...

BriaCell Therapeutics Corp. Announces Results of 2022 Annual and Special Meeting of Shareholders
January 19, 2022

NEW YORK and VANCOUVER, British Columbia, Jan. 19, 2022 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. ...

Skip to content